Irritable bowel syndrome (IBS) does not have one single established cause. It is generally understood as a disorder of gut–brain interaction in which the communication and regulation between the digestive tract and the nervous system function abnormally, producing symptoms without the structural tissue damage characteristic of inflammatory bowel disease. Several mechanisms can contribute simultaneously, and their relative importance differs between individuals.
These include altered intestinal motility, increased sensitivity of the gut to normal stretching, changes in the intestinal microbiome, altered immune signalling, food-related triggers, previous gastrointestinal infection, and psychological or physiological stress. IBS is therefore better understood as a multifactorial condition than as a disease caused by one particular food, bacterium, emotional state or anatomical abnormality. A person can have substantial abdominal pain, bloating or bowel disturbance despite having no visible ulceration or inflammation on routine examination. This distinction is important because IBS is a genuine disorder of gastrointestinal function and sensory processing rather than simply an unexplained collection of symptoms.
One important mechanism is abnormal gut motility. The intestine normally coordinates muscular contractions to mix intestinal contents and propel them towards the rectum, while the timing and strength of these contractions are influenced by nerves, hormones, immune signals and food. In some people with IBS, intestinal contents move too rapidly, contributing to loose stools or diarrhoea; in others, transit can be slower, contributing to constipation.
Some people alternate between diarrhoea and constipation and are classified as having IBS with mixed bowel habits. Motility alone does not explain all IBS symptoms, because people can experience severe pain even when the amount of intestinal movement is not obviously abnormal. The nervous system also influences how strongly intestinal sensations are perceived. Normal amounts of gas, stool or intestinal stretching can therefore be experienced as painful or uncomfortable by someone with visceral hypersensitivity. This altered sensory processing helps explain why symptoms may be disproportionate to what can be seen anatomically and why conventional scans may be normal despite significant symptoms.
The gut–brain axis is another major component of current IBS understanding. The gastrointestinal tract has an extensive intrinsic nervous system and communicates continuously with the brain through neural, hormonal and immune pathways. Signals from the brain can alter intestinal movement, secretion and sensitivity, while signals from the intestine can influence pain perception, mood and autonomic responses.
Stress does not mean that IBS is imaginary or purely psychological; rather, physiological stress responses can change gastrointestinal function and symptom perception in susceptible individuals. Anxiety, depression and other psychological factors are more common in some people with IBS and can influence symptom severity, coping and the response to treatment. Difficult early-life experiences have also been associated with IBS in research, although such associations do not mean that an individual's symptoms can automatically be attributed to past psychological events. The relationship is bidirectional and complex: persistent gastrointestinal symptoms can themselves increase anxiety, disrupt sleep, restrict activities and create additional stress, which can then intensify gastrointestinal symptoms.
Infection can precede the development of IBS in some people. This phenomenon is often described as post-infectious IBS and can occur after an episode of acute gastroenteritis. The initial infection may alter intestinal immune activity, epithelial function, microbial composition or nerve sensitivity, leaving persistent changes after the original infection has resolved. Changes in the intestinal microbiome are also being investigated extensively.
The microbiome consists of bacteria and other microorganisms living throughout the gastrointestinal tract, and studies have identified differences in microbial composition or activity in some people with IBS compared with people without IBS. However, there is not one universally accepted “IBS bacterium” or microbiome profile that explains the condition in everyone. Small intestinal bacterial overgrowth has also been investigated as a possible contributor to symptoms in some patients, but it should not be treated as the universal cause of IBS. Current evidence therefore supports a relationship between intestinal microorganisms and IBS in at least some circumstances while recognising that microbiome findings are complex and clinically heterogeneous.
Food can provoke or amplify IBS symptoms without necessarily causing the underlying disorder. Certain carbohydrates are poorly absorbed or rapidly fermented in the intestine and can increase water content, gas production and intestinal distension. These include fermentable oligosaccharides, disaccharides, monosaccharides and polyols, collectively called FODMAPs. Foods containing large amounts of particular FODMAPs can therefore trigger bloating, abdominal discomfort, diarrhoea or other symptoms in susceptible people.
Some individuals also report symptoms after fatty meals, caffeine, alcohol, spicy foods or particular individual foods. Food intolerance and food sensitivity should not automatically be equated with food allergy: an allergy involves an immune response to a specific food protein and can cause symptoms outside the gastrointestinal tract, whereas many IBS food triggers operate through digestion, fermentation, osmotic effects or altered motility. Gluten may also aggravate symptoms in some people who do not have coeliac disease, but persistent symptoms attributed to gluten should be assessed appropriately rather than assuming IBS is the explanation.
Genetic susceptibility may contribute to IBS, but IBS is not generally inherited through a simple single-gene pattern. Researchers have identified associations suggesting that genetic factors can influence susceptibility to altered pain processing, immune responses, intestinal function and interactions with the microbiome. Environmental exposures then interact with this biological predisposition. Family clustering can therefore occur without implying that a parent directly passes IBS to a child in the same way as a straightforward inherited genetic disorder.
Hormonal influences may also affect symptoms. For example, some women report increased IBS symptoms around menstruation, suggesting that reproductive hormones and cyclical physiological changes can influence gastrointestinal motility or visceral sensitivity. Other factors such as sleep disturbance, physical inactivity, acute illness, medication exposure and dietary patterns may modify symptoms without being a fundamental cause in every patient. The condition consequently represents an interaction between host biology, gastrointestinal physiology, nervous-system processing, environmental exposure and individual behaviour rather than a single identifiable lesion or pathogen.
It is important to distinguish causes of IBS from conditions that produce similar symptoms. Abdominal pain, diarrhoea, constipation and bloating can occur with coeliac disease, inflammatory bowel disease, gastrointestinal infections, colorectal cancer, endometriosis, lactose intolerance and other disorders. IBS itself does not cause visible damage to the digestive tract, whereas Crohn's disease and ulcerative colitis involve objective inflammation and tissue injury.
The absence of a single laboratory marker means clinicians diagnose IBS primarily from the characteristic symptom pattern while using appropriate investigations to exclude important alternative explanations. Alarm features such as rectal bleeding, unexplained weight loss, anaemia, persistent fever, a significant family history of bowel cancer or inflammatory bowel disease, or symptoms beginning at an unusual age can alter the diagnostic approach. Consequently, “stress causes IBS” and “IBS is just food intolerance” are both oversimplifications. Stress and food can influence symptoms, but neither explanation accounts for the full biological complexity of the disorder.
Current understanding therefore treats IBS as a multifactorial disorder arising from disturbances in gut–brain interaction, intestinal motility, visceral sensation, immune and microbial activity and responses to environmental or dietary factors. Different patients can reach the same clinical diagnosis through different combinations of mechanisms, which helps explain why one person may respond primarily to dietary modification while another benefits more from medication, psychological therapy, treatment of constipation or diarrhoea, or changes in sleep and physical activity.
There is no single diagnostic test that demonstrates “the cause” of IBS, and there is no universally applicable causal treatment because the underlying mechanisms are heterogeneous. Research continues into microbiome-targeted interventions, intestinal permeability, immune signalling, neural processing and personalised dietary and pharmacological approaches. The practical implication is that identifying an individual's predominant triggers and symptom pattern is usually more useful than searching for one universal cause. IBS is chronic and symptoms can fluctuate, but the disorder itself does not produce the progressive intestinal destruction associated with inflammatory bowel disease.
